Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.6000
-0.0400 (-6.25%)
Mar 31, 2025, 3:47 PM EDT - Market open
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $27.91 million as of March 31, 2025. Its market cap has decreased by -92.50% in one year.
Market Cap
27.91M
Enterprise Value
30.61M
1-Year Change
-92.50%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $27.91M, a decrease of -92.02%. That is a compound annual growth rate of -57.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 29.77M | -66.66% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |